NASDAQ · ICHR

Ichor Holdings

$78.30 -$8.25 (-9.53%) 1D After hours

Key Metrics

$3.02B
Market cap
P/E · TTM
$959.26M
Revenue · TTM
−$50.69M
Net income
EPS · TTM $-1.49
Dividend yield
Free cash flow −$16.76M
Beta · 1Y 4.08
EBITDA · TTM −$21.58M
Gross margin 9.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jun 30 high, the share price fell 30%.

    Peak close $112.28 on Jun 30; trough close $78.30 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -30%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 11
    The stock moved +16.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 11
  • Feb 10
    The stock moved +32.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 10

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.02B
Enterprise value$3.05B
Shares outstanding34.9M
52-wk range$13.12 – $113.58
Avg volume · 20D393.8K
Net cash −$32.95M
Book value / share$19.65
IndustrySemiconductors & Related Devices
ExchangeNASDAQ
About Ichor Holdings
IPO dateDec 9, 2016
Employees2448

Ichor Holdings Ltd designs, engineers, and manufactures critical fluid delivery subsystems and components mainly for semiconductor capital equipment, along with solutions for defense/aerospace and medical industries.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S3.15
P/FCF
EV/EBITDA
EV/Sales3.18
Graham №

Profitability

Gross 9.5%
Operating -4.6%
Net -5.3%
FCF -1.7%
ROE / ROIC -7.4% · -7.2%

Financial Health

Current ratio2.82
Quick ratio1.21
Debt / equity0.18
Debt / EBITDA -5.65
Net cash −$32.95M
Working capital$285.42M

Cash Flow · TTM

Operating CF $7.99M
Capex −$24.75M
Free cash flow −$16.76M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

7.3
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-27 · computed by TickerWolf from SEC filings